about
sameAs
Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonistUnique regulation of CCL18 production by maturing dendritic cellsFunctional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activationDendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivoSynergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effectsRegulation of the immune response by the interaction of chemokines and proteasesProteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migrationActivity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptorTruncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interactionSynthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4The CC chemokine CCL20 and its receptor CCR6.Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan InteractionsFunctional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host InsultsNatural substrates of dipeptidyl peptidase IV.Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy.Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.Role of chemokines in vernal keratoconjunctivitis.Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier BreakdownChemokine-protease interactions in cancer.PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.Synergy in cytokine and chemokine networks amplifies the inflammatory response.The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.The role of chemokines and their receptors in uveitis.Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammationThe role of CXC chemokines and their receptors in cancer.Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.The expression and role of CXC chemokines in colorectal cancer.Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.Pathogenesis of malaria-associated acute respiratory distress syndrome.CXCR3 ligands in disease and therapy.Chemokine isoforms and processing in inflammation and immunity.
P50
Q28144666-47E78472-8BBA-4CE0-9B32-D48848C7235CQ28185014-0C2998B4-9D04-452D-9CC0-FAD8F2BF053BQ28200878-65469D48-8FF2-4ED8-BDD2-13DF07689B91Q28203975-F176545E-77BE-44E0-80C7-5D9F30E5B82CQ28235478-A5299B23-3974-45FA-9977-BA0CA47E3626Q28237665-31C49843-6F75-41A8-9A10-0D21BA85201BQ28293212-A548FBC2-0AE5-4FB5-AB04-48A5D86968CCQ28293420-5372D4EF-60A0-4931-88FB-00799132E528Q28296438-0C5C9828-AFA5-4918-8553-C87AD7D62F1FQ28373491-CE24AECE-39C9-49FE-83A5-AFF5AC2D507EQ28379182-C9ECC819-2941-44E6-A3FB-DF7EC971FD8CQ30333360-D3E71AED-3DCC-46ED-965D-20F7D05D70E7Q30428793-67A8AAD3-0395-4646-84AA-E1ED67F0B032Q30848125-CB976731-3BD8-4851-A518-FDC96F9180DDQ32025761-D3254CE8-2D28-4265-A6ED-160FAE8D83ECQ33392993-7D7C5BB1-A8C5-48B6-838D-A8EB52A2AA18Q33604867-984A47AD-6DFA-45A1-87D4-8D9EE716B661Q33940767-5C342928-C677-454C-BB1B-C1EAB4C93266Q33944710-6BC6DD2E-A757-40A9-84B3-9E594E20ED20Q34181664-3DB5FE69-E8B2-44A8-A57F-4B0300032023Q34769969-B9872A2E-355B-4879-BD97-934C1C5660D0Q34786603-E76052A3-F040-449C-AEDD-4FEE71B95A01Q35051849-D9B146DF-866A-4F50-B472-0A83821B1947Q35168395-5DF39A3C-2AB9-4CB3-A45D-F42D6A522E0DQ35195333-7FAD6FA9-EA66-42F6-BA2E-4F3D86CCC305Q35832361-CFF655DF-6DBA-45EF-8C27-530BF584B66FQ35843496-46341A6E-5532-4D6C-987C-5302EE9E4DB8Q36187349-0FB08095-D91F-42A0-A686-04DB9C380E44Q36197015-D37E8619-F094-4A91-8A6A-E3E00AB47054Q36736256-6F62197B-AB1E-4184-B086-B0DB2E8FBEC5Q36790612-59D10B4F-6DF6-4586-91FF-20F2E65E394DQ36853429-97586754-6040-491E-A203-DBAA7065068CQ37200003-A841C521-7A89-4F1E-9254-3BD72B6B2FE8Q37641792-551A3786-C045-444A-892F-B9B7BDBF0B95Q37946029-9713B1E0-FD46-418E-B24D-DC0B8AEC89EEQ37946175-8A45C9AF-5ADD-4CE5-A1B5-E4722DDE7518Q37955552-326E0074-C23F-469B-ACCB-3E2BE6363D83Q38112512-222367D3-C54D-467A-9626-C7895E58397AQ38286723-8264B5DE-3FBF-4CB7-9873-E316ADF8F762Q38287788-6CB72088-5322-43AD-8FA5-730C8EF977E1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sofie Struyf
@ast
Sofie Struyf
@en
Sofie Struyf
@es
Sofie Struyf
@nl
Sofie Struyf
@sl
type
label
Sofie Struyf
@ast
Sofie Struyf
@en
Sofie Struyf
@es
Sofie Struyf
@nl
Sofie Struyf
@sl
prefLabel
Sofie Struyf
@ast
Sofie Struyf
@en
Sofie Struyf
@es
Sofie Struyf
@nl
Sofie Struyf
@sl
P1053
U-2455-2017
P106
P21
P31
P3829
P496
0000-0003-4558-0769